International Biotechnology Trust
Latest statistics and disclosures from International Biotechnology Trust's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Horizon Pharma, SGEN, INCY, ALKS, HRMY, and represent 32.62% of International Biotechnology Trust's stock portfolio.
- Added to shares of these 10 stocks: MRTX, PTCT, AZN, ILMN, TVTX, DYN, SUPN, QURE, APLS, ACAD.
- Started 3 new stock positions in AZN, APLS, ACAD.
- Reduced shares in these 10 stocks: Horizon Pharma (-$16M), GILD (-$13M), BIIB (-$6.7M), GLPG (-$5.3M), INCY, KALV, , VTRS, BMRN, IMAB.
- Sold out of its positions in AXSM, GLPG, KALV, MDGL, NBIX, VTRS.
- International Biotechnology Trust was a net seller of stock by $-25M.
- International Biotechnology Trust has $324M in assets under management (AUM), dropping by 3.82%.
- Central Index Key (CIK): 0000942257
Tip: Access up to 7 years of quarterly data
Positions held by International Biotechnology Trust consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for International Biotechnology Trust
International Biotechnology Trust holds 63 positions in its portfolio as reported in the December 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Horizon Therapeutics SHS | 11.1 | $36M | -30% | 315k | 113.75 | |
| Seagen (SGEN) | 6.6 | $21M | 166k | 128.50 | ||
| Incyte Corporation (INCY) | 5.7 | $18M | -20% | 229k | 80.31 | |
| Alkermes SHS (ALKS) | 4.8 | $16M | 593k | 26.11 | ||
| Harmony Biosciences Hldgs In (HRMY) | 4.5 | $15M | 265k | 55.05 | ||
| Uniqure N.v. Com Eur0.05 SHS (QURE) | 4.4 | $14M | +15% | 632k | 22.64 | |
| Supernus Pharmaceuticals (SUPN) | 4.2 | $14M | +28% | 384k | 35.65 | |
| Intra Cellular Therapies (ITCI) | 3.6 | $12M | 222k | 52.89 | ||
| Mirati Therapeutics (MRTX) | 3.4 | $11M | +79% | 244k | 45.31 | |
| Illumina (ILMN) | 2.9 | $9.4M | +86% | 47k | 202.08 | |
| Alnylam Pharmaceuticals (ALNY) | 2.8 | $9.0M | 38k | 237.32 | ||
| Chinook Therapeutics (KDNY) | 2.8 | $8.9M | 340k | 26.19 | ||
| Exelixis (EXEL) | 2.7 | $8.7M | 543k | 16.04 | ||
| Regeneron Pharmaceuticals (REGN) | 2.5 | $8.1M | 11k | 721.44 | ||
Setup an alertInternational Biotechnology Trust will file the next quarterly 13-HR in about 2 months. Would you like to be notified? |
||||||
| Ultragenyx Pharmaceutical (RARE) | 2.5 | $8.1M | 174k | 46.31 | ||
| Travere Therapeutics (TVTX) | 2.5 | $8.0M | +103% | 379k | 21.01 | |
| Dyne Therapeutics (DYN) | 2.3 | $7.4M | +83% | 641k | 11.57 | |
| Sanofi Sponsored Adr (SNY) | 2.1 | $6.9M | 144k | 48.38 | ||
| Biogen Idec (BIIB) | 1.8 | $5.9M | -52% | 21k | 276.80 | |
| Ptc Therapeutics I (PTCT) | 1.7 | $5.5M | +585% | 144k | 38.15 | |
| Vera Therapeutics Cl A (VERA) | 1.7 | $5.4M | 281k | 19.30 | ||
| Gilead Sciences (GILD) | 1.5 | $4.9M | -72% | 58k | 85.83 | |
| BioMarin Pharmaceutical (BMRN) | 1.4 | $4.5M | -25% | 44k | 103.41 | |
| Astrazeneca Plc Sponsored Sponsored Adr (AZN) | 1.4 | $4.4M | NEW | 65k | 67.79 | |
| Amgen (AMGN) | 1.3 | $4.3M | 16k | 262.54 | ||
| United Therapeutics Corporation (UTHR) | 1.3 | $4.2M | 15k | 278.08 | ||
| Ascendis Pharma A/s Spons Sponsored ADR (ASND) | 1.1 | $3.6M | 29k | 122.05 | ||
| Krystal Biotech (KRYS) | 1.1 | $3.6M | 45k | 79.07 | ||
| Beigene Sponsored ADR (BGNE) | 1.1 | $3.5M | 16k | 219.88 | ||
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 0.8 | $2.7M | 17k | 159.27 | ||
| Aurinia Pharmaceuticals (AUPH) | 0.8 | $2.5M | 574k | 4.32 | ||
| Zai Lab Adr (ZLAB) | 0.7 | $2.4M | 79k | 30.69 | ||
| Novocure Ord Shs (NVCR) | 0.7 | $2.3M | 32k | 73.25 | ||
| Revance Therapeutics (RVNC) | 0.7 | $2.2M | 120k | 18.45 | ||
| Guardant Health (GH) | 0.6 | $2.0M | 75k | 27.17 | ||
| Ideaya Biosciences (IDYA) | 0.6 | $2.0M | 109k | 18.17 | ||
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.6 | $1.9M | 38k | 49.85 | ||
| Apellis Pharmaceuticals (APLS) | 0.5 | $1.6M | NEW | 32k | 51.68 | |
| Caribou Biosciences (CRBU) | 0.5 | $1.6M | 258k | 6.28 | ||
| ACADIA Pharmaceuticals (ACAD) | 0.5 | $1.6M | NEW | 100k | 15.90 | |
| Fulcrum Therapeutics (FULC) | 0.4 | $1.4M | 194k | 7.27 | ||
| Crispr Therapeutics Namen Akt (CRSP) | 0.4 | $1.4M | 34k | 40.65 | ||
| Adicet Bio (ACET) | 0.4 | $1.4M | 155k | 8.92 | ||
| Novavax (NVAX) | 0.4 | $1.4M | 133k | 10.27 | ||
| Mirum Pharmaceuticals (MIRM) | 0.4 | $1.3M | +632% | 68k | 19.45 | |
| I-mab Sponsored Ads (IMAB) | 0.4 | $1.3M | -38% | 311k | 4.16 | |
| Rocket Pharmaceuticals (RCKT) | 0.4 | $1.2M | 63k | 19.54 | ||
| Concert Pharmaceuticals I equity (CNCE) | 0.4 | $1.2M | 201k | 5.84 | ||
| Denali Therapeutics (DNLI) | 0.3 | $1.1M | 38k | 27.79 | ||
| Xenon Pharmaceuticals (XENE) | 0.3 | $1.0M | 26k | 39.35 | ||
| Hutchmed China Limited Sp Sponsored Ads (HCM) | 0.3 | $1.0M | 68k | 14.75 | ||
| Beam Therapeutics (BEAM) | 0.3 | $919k | 24k | 39.11 | ||
| Intellia Therapeutics (NTLA) | 0.3 | $837k | 24k | 34.86 | ||
| Albireo Pharma (ALBO) | 0.3 | $820k | +136% | 38k | 21.59 | |
| Insmed (INSM) | 0.2 | $800k | 40k | 19.96 | ||
| Ironwood Pharmaceuticals (IRWD) | 0.2 | $743k | 60k | 12.39 | ||
| BioCryst Pharmaceuticals (BCRX) | 0.2 | $654k | 57k | 11.47 | ||
| Arvinas Ord (ARVN) | 0.2 | $581k | 17k | 34.15 | ||
| Fate Therapeutics (FATE) | 0.1 | $464k | -61% | 46k | 10.08 | |
| Iovance Biotherapeutics (IOVA) | 0.1 | $357k | 56k | 6.38 | ||
| Allogene Therapeutics (ALLO) | 0.1 | $314k | 50k | 6.28 | ||
| Black Diamond Therapeutic | 0.0 | $79k | 44k | 1.80 | ||
| Relmada Therapeutics (RLMD) | 0.0 | $35k | 10k | 3.49 | ||
Past Filings by International Biotechnology Trust
SEC 13F filings are viewable for International Biotechnology Trust going back to 2017
- International Biotechnology Trust 2022 Q4 filed Feb. 1, 2023
- International Biotechnology Trust 2022 Q3 filed Nov. 8, 2022
- International Biotechnology Trust 2022 Q2 filed Aug. 16, 2022
- International Biotechnology Trust 2022 Q1 filed May 20, 2022
- International Biotechnology Trust 2021 Q4 filed Feb. 15, 2022
- International Biotechnology Trust 2021 Q3 filed Nov. 12, 2021
- International Biotechnology Trust 2021 Q2 filed Aug. 11, 2021
- International Biotechnology Trust 2021 Q1 filed May 17, 2021
- International Biotechnology Trust 2020 Q4 filed Feb. 19, 2021
- International Biotechnology Trust 2020 Q3 filed Dec. 1, 2020
- International Biotechnology Trust 2020 Q2 filed July 14, 2020
- International Biotechnology Trust 2019 Q4 filed May 18, 2020
- International Biotechnology Trust 2020 Q1 filed May 18, 2020
- International Biotechnology Trust 2019 Q3 filed Nov. 14, 2019
- International Biotechnology Trust 2019 Q2 filed Aug. 14, 2019
- International Biotechnology Trust 2019 Q1 filed May 14, 2019